Health Condition 1: H431- Vitreous hemorrhage
Conditions
Interventions
Intervention1: Sulphur hexa fluoride gas: Parsplana vitrectomy with Sulphur hexa fluoride gas tamponade is used in the study group
Dose - 18 percent Sulphur hexa fluoride gas,
Frequency - Single inje
Sponsors
Dr Deeksha Katoch
DR SHILPA VISWANATH
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient age > 18 years 2. Non resolving vitreous hemorrhage = 4 weeks secondary to Proliferative Diabetic Retinopathy, Retinal vasculitis, Retinal vascular occlusion 3. Media clarity grade 3 and 4 4. Grade 0-2 vitreoretinal adhesion, according to the classification system described by Ahn et al given below Grade 0 Absence of vitreoretinal adhesion Grade 1 Localized adhesion at = 3 places Grade 2 Diffuse adhesion at = 1 places or adhesion to the optic nerve, macula, and/or vascular arcades Grade 3 Extensive adhesion projecting out to the peripheral retina
Exclusion criteria
Exclusion criteria: 1. Patient with Combined Retinal Detachment 2. Vitreous adhesion > grade 2 on USG 3. Patients with history of prior vitrectomy 4. Uncooperative patients i.e., inability to co-operate for surgery under local anesthesia 5. Patients not giving consent to be included in the study 6. Patients with media clarity grade 1 or 2 or visual acuity better than 6/18 7. Inability to avoid travel to high altitude 8. Patients with Neo Vascularization of Iris / Neo Vascular Glaucoma /Other ocular diseases contributing to vision loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| resolution of vitreous haemorrhage/abscence of vitreous cavity re bleedTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| best corrected visual acuityTimepoint: 3 months;requirement of repeat ppv/antivegf injectionTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Shilpa Viswanath
Post Graduate Institute of Medical Education and Research - Chandigarh
Outcome results
None listed